Sodium Bicarbonate → tert-butyl (1-(2-(4-((cyclopropylamino)carbonyl)-7-methoxy-2-oxoquinolin-1-(2H)-yl)ethyl)piperidin-4-yl)(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)carbamate

HRID 39816Notes

Reaction equation

HRID 39816 reaction equation
[CH:1]1([NH:4][C:5]([C:7]2[C:16]3[C:11](=[CH:12][C:13]([O:17][CH3:18])=[CH:14][CH:15]=3)[N:10]([CH2:19][CH:20]=O)[C:9](=[O:22])[CH:8]=2)=[O:6])[CH2:3][CH2:2]1.[O:23]1[C:28]2[CH:29]=[CH:30][C:31]([CH2:33][N:34]([CH:42]3[CH2:47][CH2:46][NH:45][CH2:44][CH2:43]3)[C:35](=[O:41])[O:36][C:37]([CH3:40])([CH3:39])[CH3:38])=[CH:32][C:27]=2[O:26][CH2:25][CH2:24]1.C([BH3-])#N.[Na+].C(=O)([O-])O.[Na+]>C(Cl)(Cl)Cl.CO.C(O)(=O)C>[CH:1]1([NH:4][C:5]([C:7]2[C:16]3[C:11](=[CH:12][C:13]([O:17][CH3:18])=[CH:14][CH:15]=3)[N:10]([CH2:19][CH2:20][N:45]3[CH2:46][CH2:47][CH:42]([N:34]([CH2:33][C:31]4[CH:30]=[CH:29][C:28]5[O:23][CH2:24][CH2:25][O:26][C:27]=5[CH:32]=4)[C:35](=[O:41])[O:36][C:37]([CH3:40])([CH3:38])[CH3:39])[CH2:43][CH2:44]3)[C:9](=[O:22])[CH:8]=2)=[O:6])[CH2:2][CH2:3]1

Participants

8

Procedure

To 1.0 mL of methanol solution containing 0.13 g of N-cyclopropyl-7-methoxy-2-oxo-1-(2-oxoethyl)-1,2-dihydroquinoline-4-carboxamide, 0.16 g of tert-butyl (2,3-dihydro-1,4-benzodioxin-6-ylmethyl)(piperidin-4-yl)carbamate and 25 μL of acetic acid were added at room temperature and stirred at the same temperature for 1.5 hours. To the reaction mixture, 42 mg of sodium cyanoborohydride was added and stirred at the same temperature for 2 hours. Further, 42 mg of sodium cyanoborohydride was added and stirred at the same temperature for 2 hours and 15 min. 76 μL of acetic acid was added and stirred at the same temperature for 2 hours. To the mixture, aqueous saturated sodium hydrogen carbonate solution was added under ice-cooling to be adjusted to pH 8.7, 5.0 mL of methanol and 15 mL of chloroform were added, the organic layer was separated, and the aqueous layer was extracted with chloroform. The organic layer and extracts were combined, washed with aqueous saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue thus obtained was purified by flash silica gel column chromatography [gradient elution of chloroform:methanol=100:0-70:30], to give 0.13 g of tert-butyl (1-(2-(4-((cyclopropylamino)carbonyl)-7-methoxy-2-oxoquinolin-1-(2H)-yl)ethyl)piperidin-4-yl)(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)carbamate as a white foam.

Workup

  1. additionwere added at room temperature
  2. stirringstirred at the same temperature for 2 hours
  3. stirringstirred at the same temperature for 2 hours and 15 min
  4. stirringstirred at the same temperature for 2 hours
  5. temperaturecooling
  6. additionwere added
  7. customthe organic layer was separated
  8. extractionthe aqueous layer was extracted with chloroform
  9. washwashed with aqueous saturated sodium chloride solution
  10. dry with materialdried over anhydrous magnesium sulfate
  11. customthe solvent was removed under reduced pressure
  12. customThe residue thus obtained
  13. customwas purified by flash silica gel column chromatography [gradient elution of chloroform:methanol=100:0-70:30]

Sources & evidence

ORD record
ord-090c0d958d6949b8bb3eb3f644065fcd
Source dataset
uspto-grants-2013_09
Patent number
US08524738B2

Reaction notes

Loading…